logo

Medtronic Plc (MDT)



Trade MDT now with
  Date
  Headline
11/22/2017 7:16:47 AM RBC Capital Markets Is Cutting Medtronic plc (MDT) Q4 18 Estimate To 1.41 From 1.43
11/22/2017 7:16:36 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) 2018 Estimate To 4.76 From 4.74
11/22/2017 7:16:06 AM RBC Capital Markets Is Lowering Medtronic plc (MDT) Q4 18 Rev. Estimate To 7.894 Billion From 7.938 Billion
11/22/2017 7:15:49 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) Q3 18 Rev. Estimate To 7.252 Billion From 7.175 Billion
11/22/2017 7:15:30 AM RBC Capital Markets Is Cutting Medtronic plc (MDT) 2019 Rev. Estimate To 30.057 Billion From 30.207 Billion
11/22/2017 7:15:16 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) 2018 Rev. Estimate To 29.586 Billion From 29.553 Billion
11/21/2017 7:14:49 AM Medtronic plc Q2 Profit Declines 6%
11/21/2017 6:54:26 AM Medtronic Q2 GAAP Net Income $2.017 Bln Or $1.48 Per Share
11/16/2017 7:52:07 AM RBC Capital Markets Is Raising Medtronic plc (MDT) Q4 18 Rev. Estimate To 7.938 Billion From 7.702 Billion
11/16/2017 7:50:24 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) Q3 18 Rev. Estimate To 7.175 Billion From 7.020 Billion
11/16/2017 7:50:02 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) Q2 18 Rev. Estimate To 7.050 Billion From 6.795 Billion
11/16/2017 7:49:47 AM RBC Capital Markets Is Raising Medtronic plc (MDT) 2019 Rev. Estimate To 30.207 Billion From 29.842 Billion
11/16/2017 7:49:28 AM RBC Capital Markets Is Raising Medtronic plc (MDT) 2018 Rev. Estimate To 29.553 Billion From 28.907 Billion
11/16/2017 7:48:34 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) Q4 18 Estimate To 1.43 From 1.38
11/16/2017 7:48:22 AM RBC Capital Markets Is Raising Medtronic plc (MDT) Q3 18 Estimate To 1.16 From 1.13
11/16/2017 7:48:09 AM RBC Capital Markets Is Raising Medtronic plc (MDT) Q2 18 Estimate To 1.03 From 0.92
11/16/2017 7:47:54 AM RBC Capital Markets Is Increasing Medtronic plc (MDT) 2018 Estimate To 4.74 From 4.55
10/5/2017 7:01:44 AM Animas Intends To Close Operations And Exit Insulin Pump Market